Compulsory Licenses

COVID-19 pandemic: ‘An opportunity of a lifetime’?

24 Apr 2020

News Research

The race is on to find an effective treatment and vaccine for COVID-19. Everyone hopes a solution will be...

Possible treatments for COVID-19 could all be made for $1 a day, say researchers: Pharma must not profit from a pandemic and countries must ACT NOW.

10 Apr 2020

Call to action News Research

Drugs currently being used in COVID-19 treatment trials can all be mass-produced affordably, research from the University of Liverpool, published...

Open letter: COVID-19 underlines the need for 37 World Trade Organization members to reverse a critical decision

9 Apr 2020

Call to action News

As the International Treatment Preparedness Coalition (ITPC), we have signed an open letter asking 37 World Trade Organization members to...

We can’t end AIDS without tackling patent abuse

25 Jan 2020

News Opinion

Despite significant scientific advancements for HIV, along with global and national commitments to ‘end AIDS’, hundreds of thousands of people...

Supporting more people to challenge injustices: A day in the life of a treatment activist

6 Sep 2019

Interview Q&A

What got you interested in treatment activism to start with? Someone in my family was struggling to access life-saving medicines....

Brazilian Health Minister’s speech on compulsory licenses exposes a disconnect with the world

7 Aug 2019

News Opinion

Adapted from a story first published by GTPI. Compulsory licensing is a vital public policy tool to combat the high...

The right to health is compulsory: Time for action on dolutegravir – now!

21 Jul 2019

Call to action News Research

Why Algeria, Azerbaijan, Belarus, Brazil, Bulgaria, China, Colombia, Kazakhstan, Mexico, Romania, Russia, and Turkey must issue compulsory licences on dolutegravir...